In fact, it all started around ten years ago when we first demonstrated that the combination of arsenic and IFN act synergistically to induce cell cycle arrest and apoptosis, specifically in HTLV-I transformed cells and fresh ATL leukemia cells, providing a biological basis for arsenic/IFN treatment in ATL [102,103]. Here, IFNA1 is linked to leukemia.